| If we build it they will come: targeting the immune response to breast cancer ME Gatti-Mays, JM Balko, SR Gameiro, HD Bear, S Prabhakaran, J Fukui, ... NPJ breast cancer 5 (1), 37, 2019 | 167 | 2019 |
| Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies J Strauss, ME Gatti-Mays, BC Cho, A Hill, S Salas, E McClay, JM Redman, ... Journal for immunotherapy of cancer 8 (2), 2020 | 89 | 2020 |
| Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy S Wilkinson, H Ye, F Karzai, SA Harmon, NT Terrigino, DJ VanderWeele, ... European urology 80 (6), 746-757, 2021 | 53 | 2021 |
| Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer HA Sater, JL Marté, RN Donahue, B Walter-Rodriguez, CR Heery, ... Journal for immunotherapy of cancer 8 (1), 2020 | 47 | 2020 |
| A phase I trial using a multitargeted recombinant adenovirus 5 (CEA/MUC1/Brachyury)‐based immunotherapy vaccine regimen in patients with advanced cancer ME Gatti‐Mays, JM Redman, RN Donahue, C Palena, RA Madan, ... The oncologist 25 (6), 479-e899, 2020 | 46 | 2020 |
| Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells Y Robbins, S Greene, J Friedman, PE Clavijo, C Van Waes, KP Fabian, ... Elife 9, e54854, 2020 | 36 | 2020 |
| Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) M Bilusic, S McMahon, RA Madan, F Karzai, YT Tsai, RN Donahue, ... Journal for immunotherapy of cancer 9 (3), 2021 | 34 | 2021 |
| The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis NH Eisa, Y Jilani, K Kainth, P Redd, S Lu, O Bougrine, HA Sater, ... Journal of Biological Chemistry 294 (14), 5246-5260, 2019 | 30 | 2019 |
| Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells MY Lee, Y Robbins, C Sievers, J Friedman, HA Sater, PE Clavijo, N Judd, ... Journal for ImmunoTherapy of Cancer 9 (3), 2021 | 24 | 2021 |
| Phase I trial of a modified vaccinia ankara priming vaccine followed by a fowlpox virus boosting vaccine modified to express brachyury and costimulatory molecules in advanced … JM Collins, RN Donahue, YT Tsai, M Manu, C Palena, ME Gatti‐Mays, ... The oncologist 25 (7), 560-e1006, 2020 | 23 | 2020 |
| A randomized phase II trial of mFOLFOX6+ bevacizumab alone or with AdCEA vaccine+ avelumab immunotherapy for untreated metastatic colorectal cancer JM Redman, YT Tsai, BA Weinberg, RN Donahue, S Gandhy, ... The Oncologist 27 (3), 198-209, 2022 | 18 | 2022 |
| Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies J Strauss, CS Floudas, HA Sater, M Manu, E Lamping, DC Francis, ... J Clin Oncol 39 (15_suppl), 2501-2501, 2021 | 17 | 2021 |
| Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis Y Robbins, J Friedman, PE Clavijo, C Sievers, K Bai, RN Donahue, ... Journal for ImmunoTherapy of Cancer 9 (8), 2021 | 15 | 2021 |
| Lung cancer trends: smoking, obesity, and sex assessed in the Staten Island University’s lung cancer patients S Gupta, S Hassan, VR Bhatt, H Abdul Sater, A Dilawari International journal of general medicine, 333-337, 2014 | 14 | 2014 |
| Therapy of established tumors with rationally designed multiple agents targeting diverse immune–tumor interactions: engage, expand, enable KP Fabian, AS Malamas, MR Padget, K Solocinski, B Wolfson, R Fujii, ... Cancer immunology research 9 (2), 239-252, 2021 | 10 | 2021 |
| Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity Z Abdul Sater, C Cero, AE Pierce, HJ Lea, H Abdul Sater, KY Zhu, N Liu, ... Obesity 30 (1), 153-164, 2022 | 9 | 2022 |
| Phase I evaluation of M7824, a bifunctional fusion protein targeting TGF-beta and PD-L1, in patients with human papillomavirus (HPV)-associated malignancies J Strauss, ME Gatti-Mays, B Cho, S Salas, E McClay, J Redman, HA Sater, ... CANCER RESEARCH 79 (13), 2019 | 9 | 2019 |
| Receptor tyrosine kinases in human platelets: a review of expression, function and inhibition in relation to the risk of bleeding or thrombocytopenia from phase I through phase … HA Sater, AS Gandhi, P Dainer, J Pantin J Cancer Prev Curr Res 8 (6), 00298, 2017 | 9 | 2017 |
| Novel designs of early phase trials for cancer therapeutics S Kummar, C Takimoto Academic Press, 2018 | 8 | 2018 |
| Elevated neutrophil: lymphocyte ratio does not predict survival in multiple myeloma patients JP Atallah, B Azab, A Vivekanandarajah, A Naboush, HA Sater, M Farhan, ... Blood, The Journal of the American Society of Hematology 122 (21), 5336-5336, 2013 | 8 | 2013 |
James L. GulleyNational Cancer InstituteVerified email at mail.nih.gov
